The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AbbVie; Bristol-Myers Squibb; Hexal; Janssen; MSD; Roche
Travel, Accommodations, Expenses - AbbVie; Bristol-Myers Squibb; Gilead Sciences; Hexal; Ipsen; Janssen; Sanofi
Sandoz rituximab (GP2013; SDZ-RTX) for the treatment of diffuse large B-cell lymphoma (DLBCL): Interim safety results of the non-interventional, observational, multicenter, open-label REFLECT study.
 
Manfred Welslau
Honoraria - Sandoz
Speakers' Bureau - Sandoz
 
Norbert Marschner
Stock and Other Ownership Interests - iOMEDICO
Consulting or Advisory Role - Sandoz
 
Thomas Wolff
No Relationships to Disclose
 
Burkhard Joerg Otremba
Honoraria - Sandoz
Consulting or Advisory Role - Sandoz
Speakers' Bureau - Sandoz
 
Julian Topaly
No Relationships to Disclose
 
Larissa Bittencourt da Silva
Employment - Sandoz-Novartis